about
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammationEffects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-AnalysisC-reactive protein, antiinflammatory drugs, and quality of life in diabetesC-reactive protein (CRP)-lowering agentsStress and health: psychological, behavioral, and biological determinantsDietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska EskimosInterleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.Systemic inflammation in cardiovascular and periodontal disease: comparative studyLipid-lowering drugs in lupus: an unexplored therapeutic intervention.Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid ANon-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease.Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndromePharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.The role of infection in the pathogenesis of cardiovascular disease.Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in bloodInflammatory pathways in children with insufficient or disordered sleep.Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations.The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseasesEffect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).Aldosterone Receptor Antagonism Reduces Urinary C-Reactive Protein Excretion in Angiotensin II-Infused, Hypertensive Rats.Avocado oil supplementation modifies cardiovascular risk profile markers in a rat model of sucrose-induced metabolic changes.Anti-inflammatory drugs as promising cardiovascular treatments.Relationship of destructive periodontal disease to the acute-phase response.Development of a high sensitivity C-reactive protein immunoassay and comparison with a commercial kit.Mediterranean diet and inflammatory response in myocardial infarction survivors.The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women.Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.Association of serum leptin with serum C-reactive protein in hemodialysis patients.Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.The relationship between attendance at religious services and cardiovascular inflammatory markers.
P2860
Q24797866-C3049A80-DBF9-4449-9AD0-0DBFA893DAD6Q26785938-A720B1FF-753A-4AD1-9BE7-90D75A135C39Q28165737-555E0CE1-98CD-4B19-8CBA-96DC1DBCE4EBQ28200344-03A464D0-7852-42D7-9257-7CC15E6C7A04Q28241987-CF938E12-6684-4561-8EFA-827740685C96Q30491678-1A71CE8C-DADB-41F7-9535-C329DBD68A40Q31143614-E784C5BC-F71D-47FC-B50A-D539BA011286Q33941972-50F23F26-2DB8-42ED-9C44-DDD46802368AQ34227152-E5BDAF9D-7B4B-44C1-BBD8-58C6F35C84C3Q34592629-E0051018-A302-43E7-868F-8D069BBA3A3BQ34604324-ECA1A978-4F8B-47A4-B546-D15779C6EC9FQ34675610-BE47CD70-77D1-4085-94E7-F86C1CE29B05Q34773911-B800DB29-9C99-45FD-BBEA-5D48F2F8B777Q35080677-E770186E-A9F7-480D-8109-03B2C0DBA73DQ35139924-4515BA7D-6920-4CAB-B1D6-80E679F963A8Q35202147-DE80CFAA-61E2-46CF-9041-9ECA10283ECFQ35554016-1C00AAAC-2C8C-4599-AECF-7B2C27E5C57AQ35576098-842805E7-E86F-4BD7-A172-955884929138Q35738921-BE5918EC-4249-44F5-9664-178C4C7DA376Q36495408-BCC8A755-A083-447A-A5DE-2A856556CFECQ37340088-22D8D6F7-66FC-455B-B80F-A36DAE247D4DQ38285387-C76FBA15-9FD1-42C2-B4B0-4C1D65E03617Q39051784-3F031039-A782-4D1E-9819-4A5DEDD93150Q39658010-C5427A39-395D-4F8A-A27C-C6D4FE2C0820Q40628986-48EA1B0B-85D9-4194-9A45-3BE4B57EC6FBQ44198614-05D245FE-FFB8-42C4-B8FE-72F2C8EE324DQ46244173-F45B4703-996C-409B-A3EF-EB692BE0F1E6Q50196870-C707CDFD-9FDC-4BEB-B04D-76161CB41931Q51137795-81A2EE19-1B63-48D4-B07F-206FAD18FA16Q51326584-F612816A-CAE7-4DDC-8D6C-EFA20D9271EEQ53441808-4A783ADC-A444-4A13-8C96-A4ECE7C2F483
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
C-reactive protein, inflammation, and coronary risk.
@ast
C-reactive protein, inflammation, and coronary risk.
@en
type
label
C-reactive protein, inflammation, and coronary risk.
@ast
C-reactive protein, inflammation, and coronary risk.
@en
prefLabel
C-reactive protein, inflammation, and coronary risk.
@ast
C-reactive protein, inflammation, and coronary risk.
@en
P1476
C-reactive protein, inflammation, and coronary risk.
@en
P2093
P304
149-61, ix
P356
10.1016/S0025-7125(05)70211-X
P577
2000-01-01T00:00:00Z